Angelique Boyer - Concepedia

Author

Angelique Boyer

University of Arizona

Also Known As

A. Boyer, A. S. Boyer, Angelique Boyer, Angelique S Boyer, Angelique S. Boyer

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Arizona Procter & Gamble (United States)Cornell University Vanderbilt University Medical Center University of Iowa

About

Angelique Boyer is an author at University of Arizona specializing in medicine, developmental biology, and drug development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	940
2	Natural Sciences	4	4	232
3	Biochemistry	4	4	232
4	Engineering	1	1	376
5	Biomedical Engineering	1	1	376

Angelique Boyer

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the Heart Christopher B. Brown, Angelique Boyer, Raymond B. Runyan, Science Cardiac MuscleHeart FailureEngineeringImmunologyBiomedical Engineering	1999	376
TGFβ2 and TGFβ3 Have Separate and Sequential Activities during Epithelial–Mesenchymal Cell Transformation in the Embryonic Heart Angelique Boyer, Ingrid I. Ayerinskas, Éric Vincent, Developmental Biology Cardiac MuscleCardiac Progenitor CellsCardiac RegenerationCell ProliferationOrgan Development	1999	200
Antibodies to the Type II TGFβ Receptor Block Cell Activation and Migration during Atrioventricular Cushion Transformation in the Heart Christopher B. Brown, Angelique Boyer, Raymond B. Runyan, Developmental Biology Developmental BiologyPhysiologyAtrioventricular Cushion TransformationCardiologyVascular Biology	1996	122
Design and synthesis of a series of novel pyrazolopyridines as HIF 1-α prolyl hydroxylase inhibitors Namal C. Warshakoon, Shengde Wu, Angelique Boyer, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryNovel PyrazolopyridinesBiochemistryMedicine	2006	73
A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors Namal C. Warshakoon, Shengde Wu, Angelique Boyer, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNovel SeriesBiochemistryNatural SciencesMedicine	2006	64
Epithelial-mesenchymal transformation in the embryonic heart is mediated through distinct pertussis toxin-sensitive and TGF? signal transduction mechanisms Angelique Boyer, Christof P Erickson, Raymond B. Runyan Developmental Dynamics	1999	60
Trichloroethylene Inhibits Development of Embryonic Heart Valve Precursors in Vitro Angelique Boyer Toxicological Sciences	2000	57
Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors Namal C. Warshakoon, Shengde Wu, Angelique Boyer, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistrySar EvaluationMedicineNatural Sciences	2006	56
TGFβ Type III and TGFβ Type II receptors have distinct activities during epithelial–mesenchymal cell transformation in the embryonic heart Angelique Boyer, Raymond B. Runyan Developmental Dynamics	2001	44
Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors Namal C. Warshakoon, Shengde Wu, Angelique Boyer, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryDerivative (Chemistry)BiochemistryMedicine	2006	39

Page 1